Qualcomm Life is a subsidiary of San Diego's mobile chip maker Qualcomm, which specializes in healthcare . The company announced on Monday that it has acquired Capsule Tech, a company that helps healthcare organizations collect and process medical device data.
The financial terms of this acquisition were not disclosed. Qualcomm is a capsule technology bought from two companies, JMI Equity and Bulger Capital Partners, which have held a majority stake in capsule technology since 2012.
Qualcomm's main product, 2Net, is a home gateway device that collects and encrypts biometric data generated by medical devices used by patients. Once the data is collected, the gateway device sends it to a cloud backend for easy access by a doctor or medical facility. This allows the doctor to better track the patient's condition while the patient is at home.
Capsule Technology was founded in 1997. The company in Andover, Massachusetts is similar to Qualcomm, except that it has become a medical device placed in hospitals and other health care clinics. Capsule Technology creates hardware that converts the data generated by medical devices into digital information and then transmits this data to the back-end management system.
Through this acquisition, Qualcomm's goal is to create a more comprehensive platform for patient health tracking.
“With Capsule Technology, we have the largest ecosystem of connected medical devices,†said Rick Valencia, senior vice president and general manager of Qualcomm Life. “We are extending our business to the home, The hospital, and all the nodes between the two links, that is, where the patient is likely to be. We will create a connected organizational structure and transfer all of this data back to the system."
Qualcomm's best-known products are today's chips used in a variety of advanced Android smartphones, but the company has been looking for new markets that can drive its future growth. The smartphone market on which most of the wealth is based is undergoing some major changes. For many established companies, it is becoming more and more difficult to make good profits from this market. The top market is further consolidated by Apple, while Chinese handset manufacturers are offering ever-higher quality products at lower prices.
Like many other technology giants, the next major growth opportunity for Qualcomm is the Internet of Things, a broader concept for fast-growing, intelligent networking devices around the world. Qualcomm's 2Net products fall into this category. About four years ago, the company began developing 2Net, which is currently sold to more than 500 companies to help collect medical data from patients at home.
"The idea of ​​launching 2Net is that there will be fundamental changes in the delivery of healthcare services," Valencia said.
Shaanxi Kang New Pharmaceutical co., Ltd. , https://www.apipepdites.com